Chinese Markets for Brain Cancer Treatment Drugs

Asia Market Information & Development Company
September 1, 2009
197 Pages - SKU: ASM2435499
License type:
Countries covered: China

China's demand for Brain Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.


More China Oncology/Hematology Reports

Factors Influencing Morbidity Trends in BRIC Countries by Decision Resources
The WHO projects that, over the next ten years, the largest increase in deaths from cardiovascular disease, cancer, respiratory disease, and diabetes will occur in ...

China Oncology Prescription Drug Sales Data 2007-2010 by Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...

Oncology Market Access in China - Market bolstered by rising incidence and improved regulatory environment by Datamonitor
Introduction The increasing adoption of Westernized lifestyles coupled with ongoing economic development is driving up the number of cancer patients in China. Increased healthcare spending and ...

Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market by GBI Research
Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market Summary GBI Research, the ...

Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 by GlobalData
Prostate Cancer - BRIC Drug Forecasts and Treatment Analysis to 2020 Summary GlobalData's pharmaceutical report, “Prostate Cancer - Brazil, Russia, India and China ...

See all reports like this >>

More China Reports

D&B Country RiskLine Report: China by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

Country Report China February 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

Country Report China January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

D&B Country Report: China by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Juice – China – a snapshot (2010) by Mintel - Snapshots
Juice in China by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. The report covers packaged ...

See all reports like this >>